Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Siguo Hao

Showing results (21-30 of 61) with videos related to

Pageof 7
Sort By:
Cancer Biotherapy & Radiopharmaceuticals|July 2, 2005
Significant tumor regression induced by microencapsulation of recombinant tumor cells secreting fusion proteinMeiqing Shi, Siguo Hao, Mabood Quereshi, et al.
Immunology|February 3, 2007
CD4+ Th1 cells promote CD8+ Tc1 cell survival, memory response, tumor localization and therapy by targeted delivery of interleukin 2 via acquired pMHC I complexesHui Huang, Siguo Hao, Fang Li, et al.
Frontiers in Immunology|December 5, 2022
A novel costimulatory molecule gene-modified leukemia cell-derived exosome-targeted CD4<sup>+</sup> T cell vaccine efficiently enhances anti-leukemia immunityJiaqi Li, Fang Huang, Yan Jiang, et al.
The Oncologist|August 24, 2023
Selinexor With Anti-PD-1 Antibody as a Potentially Effective Regimen for Patients With Natural Killer/T-Cell Lymphoma Failing Prior L-Asparaginase and PD-1 BlockadeRong Tao, Chuanxu Liu, Wenhao Zhang, et al.
Cancer Immunology, Immunotherapy : CII|June 12, 2017
TGF-β1-silenced leukemia cell-derived exosomes target dendritic cells to induce potent anti-leukemic immunity in a mouse modelFang Huang, Jiangbo Wan, Siguo Hao, et al.
Acta Haematologica|February 28, 2019
Autologous Stem Cell Transplantation Is a Viable Postremission Therapy for Intermediate-Risk Acute Myeloid Leukemia in First Complete Remission in the Absence of a Matched Identical Sibling: A Meta-AnalysisZhichao Li, Yinmei Liu, Qing Wang, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|July 21, 2015
Comparison of human coagulation factor VIII expression directed by cytomegalovirus and mammary gland-specific promoters in HC11 cells and transgenic miceQing Wang, Siguo Hao, Liyuan Ma, et al.
Immunology|November 1, 2006
Mature dendritic cells pulsed with exosomes stimulate efficient cytotoxic T-lymphocyte responses and antitumour immunitySiguo Hao, Ou Bai, Fang Li, et al.
Journal of Cellular and Molecular Medicine|November 30, 2019
Enhanced alleviation of aGVHD by TGF-β1-modified mesenchymal stem cells in mice through shifting MΦ into M2 phenotype and promoting the differentiation of Treg cellsRan Wu, Chuanxu Liu, Xiaohui Deng, et al.
Cancer Biotherapy & Radiopharmaceuticals|July 2, 2005
Molecular and immunophenotypical characterization of progressive and regressive leukemia cell linesSiguo Hao, Xuguang Bi, Liping Su, et al.
Pageof 7

Showing results (21-30 of 61) with videos related to

Sort By:
Pageof 7
Cancer Biotherapy & Radiopharmaceuticals|July 2, 2005
Significant tumor regression induced by microencapsulation of recombinant tumor cells secreting fusion proteinMeiqing Shi, Siguo Hao, Mabood Quereshi, et al.
Immunology|February 3, 2007
CD4+ Th1 cells promote CD8+ Tc1 cell survival, memory response, tumor localization and therapy by targeted delivery of interleukin 2 via acquired pMHC I complexesHui Huang, Siguo Hao, Fang Li, et al.
Frontiers in Immunology|December 5, 2022
A novel costimulatory molecule gene-modified leukemia cell-derived exosome-targeted CD4<sup>+</sup> T cell vaccine efficiently enhances anti-leukemia immunityJiaqi Li, Fang Huang, Yan Jiang, et al.
The Oncologist|August 24, 2023
Selinexor With Anti-PD-1 Antibody as a Potentially Effective Regimen for Patients With Natural Killer/T-Cell Lymphoma Failing Prior L-Asparaginase and PD-1 BlockadeRong Tao, Chuanxu Liu, Wenhao Zhang, et al.
Cancer Immunology, Immunotherapy : CII|June 12, 2017
TGF-β1-silenced leukemia cell-derived exosomes target dendritic cells to induce potent anti-leukemic immunity in a mouse modelFang Huang, Jiangbo Wan, Siguo Hao, et al.
Acta Haematologica|February 28, 2019
Autologous Stem Cell Transplantation Is a Viable Postremission Therapy for Intermediate-Risk Acute Myeloid Leukemia in First Complete Remission in the Absence of a Matched Identical Sibling: A Meta-AnalysisZhichao Li, Yinmei Liu, Qing Wang, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|July 21, 2015
Comparison of human coagulation factor VIII expression directed by cytomegalovirus and mammary gland-specific promoters in HC11 cells and transgenic miceQing Wang, Siguo Hao, Liyuan Ma, et al.
Immunology|November 1, 2006
Mature dendritic cells pulsed with exosomes stimulate efficient cytotoxic T-lymphocyte responses and antitumour immunitySiguo Hao, Ou Bai, Fang Li, et al.
Journal of Cellular and Molecular Medicine|November 30, 2019
Enhanced alleviation of aGVHD by TGF-β1-modified mesenchymal stem cells in mice through shifting MΦ into M2 phenotype and promoting the differentiation of Treg cellsRan Wu, Chuanxu Liu, Xiaohui Deng, et al.
Cancer Biotherapy & Radiopharmaceuticals|July 2, 2005
Molecular and immunophenotypical characterization of progressive and regressive leukemia cell linesSiguo Hao, Xuguang Bi, Liping Su, et al.
Pageof 7